A method and a device for determining the hydration and/or nutrition status of a patient
CA 2562875 C · Owner: Fresenius Medical Care Deutschland Gmbh · Inventors: Wabel, Peter; Chamney, Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monitoring the hydration and/or nutrition status of a patient by bioimpedance. A bioimpedance method and device that makes use of a refined model by which the conductivity contributions from intracellular tissues can be taken better into account to enable an improved assessment of the body composition of a patient with increased accuracy. The intracellular volume (ICV) of a patient is determined by determining an intracellular electrical resistance Rmix of the patient and deriving the intracellular volume ICV using Rmix by taking into account that a cell of a kind of tissue contributes differently to the electrical resistance Rmix of the intracellular volume ICV compared with a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2004 and granted June 17, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 29, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.